BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Amodio P, Del Piccolo F, Marchetti P, Angeli P, Iemmolo R, Caregaro L, Merkel C, Gerunda G, Gatta A. Clinical features and survivial of cirrhotic patients with subclinical cognitive alterations detected by the number connection test and computerized psychometric tests. Hepatology. 1999;29:1662-1667. [PMID: 10347105 DOI: 10.1002/hep.510290619] [Cited by in Crossref: 175] [Cited by in F6Publishing: 160] [Article Influence: 7.6] [Reference Citation Analysis]
Number Citing Articles
1 Mandell MS, Lezotte D, Kam I, Zamudio S. Reduced use of intensive care after liver transplantation: patient attributes that determine early transfer to surgical wards. Liver Transpl 2002;8:682-7. [PMID: 12149760 DOI: 10.1053/jlts.2002.34380] [Cited by in Crossref: 36] [Cited by in F6Publishing: 21] [Article Influence: 1.9] [Reference Citation Analysis]
2 Grewal P, Martin P. Care of the cirrhotic patient. Clin Liver Dis 2009;13:331-40. [PMID: 19442922 DOI: 10.1016/j.cld.2009.02.006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
3 Vilstrup H, Amodio P, Bajaj J, Cordoba J, Ferenci P, Mullen KD, Weissenborn K, Wong P. Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver. Hepatology. 2014;60:715-735. [PMID: 25042402 DOI: 10.1002/hep.27210] [Cited by in Crossref: 879] [Cited by in F6Publishing: 680] [Article Influence: 109.9] [Reference Citation Analysis]
4 Iqbal U, Jadeja RN, Khara HS, Khurana S. A Comprehensive Review Evaluating the Impact of Protein Source (Vegetarian vs. Meat Based) in Hepatic Encephalopathy. Nutrients 2021;13:370. [PMID: 33530344 DOI: 10.3390/nu13020370] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Sharma P, Sharma BC, Sarin SK. Predictors of nonresponse to lactulose for minimal hepatic encephalopathy in patients with cirrhosis. Liver Int. 2009;29:1365-1371. [PMID: 19555401 DOI: 10.1111/j.1478-3231.2009.02067.x] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 2.3] [Reference Citation Analysis]
6 Srivastava A, Chaturvedi S, Gupta RK, Malik R, Mathias A, Jagannathan NR, Jain S, Pandey CM, Yachha SK, Rathore RKS. Minimal hepatic encephalopathy in children with chronic liver disease: Prevalence, pathogenesis and magnetic resonance-based diagnosis. Journal of Hepatology 2017;66:528-36. [DOI: 10.1016/j.jhep.2016.10.026] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
7 Riggio O, Ridola L, Pasquale C. Hepatic encephalopathy therapy: An overview. World J Gastrointest Pharmacol Ther 2010; 1(2): 54-63 [PMID: 21577297 DOI: 10.4292/wjgpt.v1.i2.54] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
8 Amodio P, Montagnese S. Lights and Shadows in Hepatic Encephalopathy Diagnosis. J Clin Med 2021;10:341. [PMID: 33477554 DOI: 10.3390/jcm10020341] [Reference Citation Analysis]
9 Olesen SS, Gram M, Jackson CD, Halliday E, Sandberg TH, Drewes AM, Morgan MY. Electroencephalogram variability in patients with cirrhosis associates with the presence and severity of hepatic encephalopathy. J Hepatol 2016;65:517-23. [PMID: 27184531 DOI: 10.1016/j.jhep.2016.05.004] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 2.7] [Reference Citation Analysis]
10 Bajaj JS, Saeian K, Verber MD, Hischke D, Hoffmann RG, Franco J, Varma RR, Rao SM. Inhibitory control test is a simple method to diagnose minimal hepatic encephalopathy and predict development of overt hepatic encephalopathy. Am J Gastroenterol. 2007;102:754-760. [PMID: 17222319 DOI: 10.1111/j.1572-0241.2007.01048.x] [Cited by in Crossref: 108] [Cited by in F6Publishing: 94] [Article Influence: 7.2] [Reference Citation Analysis]
11 Romero-gómez M, Grande L, Camacho I. Prognostic value of altered oral glutamine challenge in patients with minimal hepatic encephalopathy. Hepatology 2004;39:939-43. [DOI: 10.1002/hep.20152] [Cited by in Crossref: 50] [Cited by in F6Publishing: 46] [Article Influence: 2.8] [Reference Citation Analysis]
12 Sharma P, Kumar A, Singh S, Tyagi P, Kumar A. Inhibitory control test, critical flicker frequency, and psychometric tests in the diagnosis of minimal hepatic encephalopathy in cirrhosis. Saudi J Gastroenterol. 2013;19:40-44. [PMID: 23319037 DOI: 10.4103/1319-3767.105924] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
13 Dhiman RK, Kurmi R, Thumburu KK, Venkataramarao SH, Agarwal R, Duseja A, Chawla Y. Diagnosis and prognostic significance of minimal hepatic encephalopathy in patients with cirrhosis of liver. Dig Dis Sci. 2010;55:2381-2390. [PMID: 20508990 DOI: 10.1007/s10620-010-1249-7] [Cited by in Crossref: 128] [Cited by in F6Publishing: 119] [Article Influence: 10.7] [Reference Citation Analysis]
14 Nardelli S, Lattanzi B, Merli M, Farcomeni A, Gioia S, Ridola L, Riggio O. Muscle Alterations Are Associated With Minimal and Overt Hepatic Encephalopathy in Patients With Liver Cirrhosis. Hepatology. 2019;70:1704-1713. [PMID: 31038758 DOI: 10.1002/hep.30692] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 9.3] [Reference Citation Analysis]
15 Nardelli S, Gioia S, Ridola L, Carlin M, Cioffi AD, Merli M, Riggio O, Spagnoli A. Risk of falls in patients with cirrhosis evaluated by timed up and go test: Does muscle or brain matter more? Dig Liver Dis 2021:S1590-8658(21)00333-9. [PMID: 34233863 DOI: 10.1016/j.dld.2021.06.019] [Reference Citation Analysis]
16 Swaminathan M, Ellul MA, Cross TJ. Hepatic encephalopathy: current challenges and future prospects. Hepat Med. 2018;10:1-11. [PMID: 29606895 DOI: 10.2147/hmer.s118964] [Cited by in Crossref: 23] [Cited by in F6Publishing: 8] [Article Influence: 5.8] [Reference Citation Analysis]
17 Kircheis G, Fleig WE, Görtelmeyer R, Grafe S, Häussinger D. Assessment of low-grade hepatic encephalopathy: a critical analysis. J Hepatol 2007;47:642-50. [PMID: 17869373 DOI: 10.1016/j.jhep.2007.05.019] [Cited by in Crossref: 51] [Cited by in F6Publishing: 41] [Article Influence: 3.4] [Reference Citation Analysis]
18 Schiff S, Vallesi A, Mapelli D, Orsato R, Pellegrini A, Umiltà C, Gatta A, Amodio P. Impairment of Response Inhibition Precedes Motor Alteration in the Early Stage of Liver Cirrhosis: A Behavioral and Electrophysiological Study. Metab Brain Dis 2005;20:381-92. [DOI: 10.1007/s11011-005-7922-4] [Cited by in Crossref: 49] [Cited by in F6Publishing: 45] [Article Influence: 2.9] [Reference Citation Analysis]
19 Pascoli D, Guérit J, Montagnese S, de Tourtchaninoff M, Minelli T, Pellegrini A, Del Piccolo F, Gatta A, Amodio P. Analysis of EEG tracings in frequency and time domain in hepatic encephalopathy. Computer Methods and Programs in Biomedicine 2006;81:203-12. [DOI: 10.1016/j.cmpb.2005.10.009] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
20 Montoliu C, Rodrigo R, Monfort P, Llansola M, Cauli O, Boix J, Elmlili N, Agusti A, Felipo V. Cyclic GMP pathways in hepatic encephalopathy. Neurological and therapeutic implications. Metab Brain Dis. 2010;25:39-48. [PMID: 20195723 DOI: 10.1007/s11011-010-9184-z] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 2.5] [Reference Citation Analysis]
21 Dhiman RK, Chawla YK. Minimal hepatic encephalopathy. Indian J Gastroenterol. 2009;28:5-16. [PMID: 19529896 DOI: 10.1007/s12664-009-0003-6] [Cited by in Crossref: 63] [Cited by in F6Publishing: 52] [Article Influence: 4.8] [Reference Citation Analysis]
22 Bajaj JS. Diagnosing minimal hepatic encephalopathy: from the ivory tower to the real world. Gastroenterology 2015;149:1330-3. [PMID: 26416330 DOI: 10.1053/j.gastro.2015.09.028] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
23 Kornerup LS, Pflugrad H, Weissenborn K, Vilstrup H, Dam G. Cognitive impairment after liver transplantation: residual hepatic encephalopathy or posttransplant encephalopathy? Hepat Med 2019;11:41-6. [PMID: 31040728 DOI: 10.2147/HMER.S144667] [Cited by in Crossref: 4] [Article Influence: 1.3] [Reference Citation Analysis]
24 Bajaj JS, Wade JB, Sanyal AJ. Spectrum of neurocognitive impairment in cirrhosis: Implications for the assessment of hepatic encephalopathy. Hepatology. 2009;50:2014-2021. [PMID: 19787808 DOI: 10.1002/hep.23216] [Cited by in Crossref: 223] [Cited by in F6Publishing: 198] [Article Influence: 17.2] [Reference Citation Analysis]
25 Zhan T, Stremmel W. The diagnosis and treatment of minimal hepatic encephalopathy. Dtsch Arztebl Int. 2012;109:180-187. [PMID: 22470407 DOI: 10.3238/arztebl.2012.0180] [Cited by in Crossref: 9] [Cited by in F6Publishing: 14] [Article Influence: 0.9] [Reference Citation Analysis]
26 Amodio P, Marchetti P, Del Piccolo F, de Tourtchaninoff M, Varghese P, Zuliani C, Campo G, Gatta A, Guérit J. Spectral versus visual EEG analysis in mild hepatic encephalopathy. Clinical Neurophysiology 1999;110:1334-44. [DOI: 10.1016/s1388-2457(99)00076-0] [Cited by in Crossref: 130] [Cited by in F6Publishing: 28] [Article Influence: 5.7] [Reference Citation Analysis]
27 Amodio P, Montagnese S, Merkel C. Attention: Minimal hepatic encephalopathy and road accidents. Hepatology 2012;55:985-7. [PMID: 22234933 DOI: 10.1002/hep.25583] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
28 Mullen KD, Amodio P, Morgan MY. Therapeutic studies in hepatic encephalopathy. Metab Brain Dis 2007;22:407-23. [DOI: 10.1007/s11011-007-9061-6] [Cited by in Crossref: 23] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
29 Ridola L, Cardinale V, Riggio O. The burden of minimal hepatic encephalopathy: From diagnosis to therapeutic strategies. Ann Gastroenterol. 2018;31:151-164. [PMID: 29507462 DOI: 10.20524/aog.2018.0232] [Cited by in Crossref: 8] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
30 Djiambou-Nganjeu H. Hepatic Encephalopathy in Patients in Lviv (Ukraine). J Transl Int Med. 2018;6:146-151. [PMID: 30425951 DOI: 10.2478/jtim-2018-0021] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
31 Sharma P, Sharma BC. Lactulose for minimal hepatic encephalopathy in patients with extrahepatic portal vein obstruction. Saudi J Gastroenterol 2012;18:168-72. [PMID: 22626795 DOI: 10.4103/1319-3767.96448] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
32 Riggio O, Ridola L. Emerging drugs for hepatic encephalopathy. Expert Opin Emerg Drugs 2009;14:537-49. [PMID: 19552607 DOI: 10.1517/14728210903055067] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
33 Kappus MR, Bajaj JS. Covert hepatic encephalopathy: Not as minimal as you might think. Clin Gastroenterol Hepatol. 2012;10:1208-1219. [PMID: 22728384 DOI: 10.1016/j.cgh.2012.05.026] [Cited by in Crossref: 55] [Cited by in F6Publishing: 41] [Article Influence: 5.5] [Reference Citation Analysis]
34 Zhou Y, Chen S, Jiang L, Guo C, Shen Z, Huang P, Wang J. Development and evaluation of the quality of life instrument in chronic liver disease patients with minimal hepatic encephalopathy. Journal of Gastroenterology and Hepatology 2009;24:408-15. [DOI: 10.1111/j.1440-1746.2008.05678.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
35 De Rui M, Montagnese S, Amodio P. Recent developments in the diagnosis and treatment of covert/minimal hepatic encephalopathy. Expert Rev Gastroenterol Hepatol 2016;10:443-50. [PMID: 26758861 DOI: 10.1586/17474124.2016.1141675] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
36 Ponziani FR, Funaro B, Lupascu A, Ainora ME, Garcovich M, Caracciolo G, Quadarella A, Nesci A, Riccardi L, Gasbarrini A, Pompili M, Zocco MA. Minimal Hepatic Encephalopathy is Associated with Increased Cerebral Vascular Resistance. A Transcranial Doppler Ultrasound Study. Sci Rep 2019;9:15373. [PMID: 31653939 DOI: 10.1038/s41598-019-51867-6] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
37 Riggio O, Ridola L, Pasquale C, Nardelli S, Pentassuglio I, Moscucci F, Merli M. Evidence of Persistent Cognitive Impairment After Resolution of Overt Hepatic Encephalopathy. Clinical Gastroenterology and Hepatology 2011;9:181-3. [DOI: 10.1016/j.cgh.2010.10.002] [Cited by in Crossref: 71] [Cited by in F6Publishing: 70] [Article Influence: 6.5] [Reference Citation Analysis]
38 Bhanji RA, Carey EJ, Watt KD. Review article: maximising quality of life while aspiring for quantity of life in end-stage liver disease. Aliment Pharmacol Ther. 2017;46:16-25. [PMID: 28464346 DOI: 10.1111/apt.14078] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
39 Nakanishi H, Hayakawa Y, Kubota Y, Kurosaki M, Osawa L, Inada K, Kirino S, Yamashita K, Sekiguchi S, Okada M, Wan W, Higuchi M, Takaura K, Maeyashiki C, Kaneko S, Tamaki N, Yasui Y, Noda T, Nakanishi K, Tsuchiya K, Itakura J, Takahashi Y, Izumi N. Impaired brain function improved by L-carnitine in patients with cirrhosis: evaluation using near-infrared spectroscopy. Sci Rep 2020;10:13566. [PMID: 32782294 DOI: 10.1038/s41598-020-70585-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
40 Jain L, Sharma BC, Srivastava S, Puri SK, Sharma P, Sarin S. Serum endotoxin, inflammatory mediators, and magnetic resonance spectroscopy before and after treatment in patients with minimal hepatic encephalopathy. J Gastroenterol Hepatol. 2013;28:1187-1193. [PMID: 23425082 DOI: 10.1111/jgh.12160] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 4.8] [Reference Citation Analysis]
41 Malaguarnera M, Bella R, Vacante M, Giordano M, Malaguarnera G, Gargante MP, Motta M, Mistretta A, Rampello L, Pennisi G. Acetyl-L-carnitine reduces depression and improves quality of life in patients with minimal hepatic encephalopathy. Scand J Gastroenterol. 2011;46:750-759. [PMID: 21443422 DOI: 10.3109/00365521.2011.565067] [Cited by in Crossref: 54] [Cited by in F6Publishing: 48] [Article Influence: 4.9] [Reference Citation Analysis]
42 Morgan MY, Amodio P, Cook NA, Jackson CD, Kircheis G, Lauridsen MM, Montagnese S, Schiff S, Weissenborn K. Qualifying and quantifying minimal hepatic encephalopathy. Metab Brain Dis 2016;31:1217-29. [PMID: 26412229 DOI: 10.1007/s11011-015-9726-5] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 3.7] [Reference Citation Analysis]
43 Nabi E, Bajaj JS. Useful tests for hepatic encephalopathy in clinical practice. Curr Gastroenterol Rep. 2014;16:362. [PMID: 24357348 DOI: 10.1007/s11894-013-0362-0] [Cited by in Crossref: 28] [Cited by in F6Publishing: 18] [Article Influence: 3.5] [Reference Citation Analysis]
44 Michitaka K, Hiraoka A, Kume M, Uehara T, Hidaka S, Ninomiya T, Hasebe A, Miyamoto Y, Ichiryu M, Tanihira T. Amino acid imbalance in patients with chronic liver diseases. Hepatol Res. 2010;40:393-398. [PMID: 20236360 DOI: 10.1111/j.1872-034x.2009.00614.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 12] [Article Influence: 2.1] [Reference Citation Analysis]
45 Wein C, Koch H, Popp B, Oehler G, Schauder P. Minimal hepatic encephalopathy impairs fitness to drive. Hepatology 2004;39:739-45. [DOI: 10.1002/hep.20095] [Cited by in Crossref: 215] [Cited by in F6Publishing: 181] [Article Influence: 11.9] [Reference Citation Analysis]
46 Yoo HY, Edwin D, Thuluvath PJ. Relationship of The Model for End-Stage Liver Disease (Meld) Scale To Hepatic Encephalopathy, As Defined by Electroencephalography and Neuropsychometric Testing, and Ascites. American Journal of Gastroenterology 2003;98:1395-9. [DOI: 10.1111/j.1572-0241.2003.07466.x] [Cited by in Crossref: 63] [Cited by in F6Publishing: 58] [Article Influence: 3.3] [Reference Citation Analysis]
47 Mittal VV, Sharma BC, Sharma P, Sarin SK. A randomized controlled trial comparing lactulose, probiotics, and L-ornithine L-aspartate in treatment of minimal hepatic encephalopathy. Eur J Gastroenterol Hepatol. 2011;23:725-732. [PMID: 21646910 DOI: 10.1097/meg.0b013e32834696f5] [Cited by in Crossref: 118] [Cited by in F6Publishing: 49] [Article Influence: 10.7] [Reference Citation Analysis]
48 Sunil HV, Mittal BR, Kurmi R, Chawla YK, Dhiman RK. Brain perfusion single photon emission computed tomography abnormalities in patients with minimal hepatic encephalopathy. J Clin Exp Hepatol 2012;2:116-21. [PMID: 25755420 DOI: 10.1016/S0973-6883(12)60099-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
49 Campagna F, Montagnese S, Ridola L, Senzolo M, Schiff S, De Rui M, Pasquale C, Nardelli S, Pentassuglio I, Merkel C, Angeli P, Riggio O, Amodio P. The animal naming test: An easy tool for the assessment of hepatic encephalopathy. Hepatology. 2017;66:198-208. [PMID: 28271528 DOI: 10.1002/hep.29146] [Cited by in Crossref: 53] [Cited by in F6Publishing: 46] [Article Influence: 10.6] [Reference Citation Analysis]
50 American Association for the Study of Liver Diseases. Hepatic encephalopathy in chronic liver disease: 2014 practice guideline by the European Association for the Study of the Liver and the American Association for the Study of Liver Diseases. J Hepatol. 2014;61:642-659. [PMID: 25015420 DOI: 10.1016/j.jhep.2014.05.042] [Cited by in Crossref: 212] [Cited by in F6Publishing: 164] [Article Influence: 26.5] [Reference Citation Analysis]
51 Romero-Gómez M, Grande L, Camacho I, Benitez S, Irles JA, Castro M. Altered response to oral glutamine challenge as prognostic factor for overt episodes in patients with minimal hepatic encephalopathy. J Hepatol 2002;37:781-7. [PMID: 12445419 DOI: 10.1016/s0168-8278(02)00330-6] [Cited by in Crossref: 51] [Cited by in F6Publishing: 11] [Article Influence: 2.7] [Reference Citation Analysis]
52 Montagnese S, Russo FP, Amodio P, Burra P, Gasbarrini A, Loguercio C, Marchesini G, Merli M, Ponziani FR, Riggio O, Scarpignato C. Hepatic encephalopathy 2018: A clinical practice guideline by the Italian Association for the Study of the Liver (AISF). Dig Liver Dis. 2019;51:190-205. [PMID: 30606696 DOI: 10.1016/j.dld.2018.11.035] [Cited by in Crossref: 30] [Cited by in F6Publishing: 18] [Article Influence: 7.5] [Reference Citation Analysis]
53 Formentin C, De Rui M, Zoncapè M, Ceccato S, Zarantonello L, Senzolo M, Burra P, Angeli P, Amodio P, Montagnese S. The psychomotor vigilance task: Role in the diagnosis of hepatic encephalopathy and relationship with driving ability. Journal of Hepatology 2019;70:648-57. [DOI: 10.1016/j.jhep.2018.12.031] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
54 Dávalos Moscol M, Bustios Sanchez C. The burden of hepatic encephalopathy in Latin America. Annals of Hepatology 2011;10:S31-5. [DOI: 10.1016/s1665-2681(19)31603-5] [Cited by in Crossref: 4] [Article Influence: 0.4] [Reference Citation Analysis]
55 Varakanahalli S, Sharma BC, Srivastava S, Sachdeva S, Dahale AS. Secondary prophylaxis of hepatic encephalopathy in cirrhosis of liver: a double-blind randomized controlled trial of L-ornithine L-aspartate versus placebo. Eur J Gastroenterol Hepatol 2018;30:951-8. [PMID: 29727385 DOI: 10.1097/MEG.0000000000001137] [Cited by in Crossref: 14] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
56 Kircheis G, Wettstein M, Timmermann L, Schnitzler A, Häussinger D. Critical flicker frequency for quantification of low-grade hepatic encephalopathy. Hepatology. 2002;35:357-366. [PMID: 11826409 DOI: 10.1053/jhep.2002.30957] [Cited by in Crossref: 279] [Cited by in F6Publishing: 234] [Article Influence: 14.0] [Reference Citation Analysis]
57 Michitaka K, Tokumoto Y, Uesugi K, Kisaka Y, Hirooka M, Konishi I, Mashiba T, Abe M, Hiasa Y, Matsuura B, Horiike N, Shoda T, Onji M. Neuropsychiatric dysfunction in patients with chronic hepatitis and liver cirrhosis. Hepatology Research 2008;38:1069-75. [DOI: 10.1111/j.1872-034x.2008.00374.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 3] [Article Influence: 0.9] [Reference Citation Analysis]
58 Bajaj JS, Thacker LR, Heuman DM, Sterling RK, Stravitz RT, Sanyal AJ, Luketic V, Fuchs M, Gilles HC, Wade JB. Cognitive performance as a predictor of hepatic encephalopathy in pretransplant patients with cirrhosis receiving psychoactive medications: a prospective study. Liver Transpl. 2012;18:1179-1187. [PMID: 22674517 DOI: 10.1002/lt.23484] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 2.8] [Reference Citation Analysis]
59 Ferenci P, Lockwood A, Mullen K, Tarter R, Weissenborn K, Blei AT. Hepatic encephalopathy-Definition, nomenclature, diagnosis, and quantification: Final report of the Working Party at the 11th World Congresses of Gastroenterology, Vienna, 1998: Hepatic encephalopathy-Definition, nomenclature, diagnosis, and quantification: Final report of the Working Party at the 11th World Congresses of Gast. Hepatology 2002;35:716-21. [DOI: 10.1053/jhep.2002.31250] [Cited by in Crossref: 1381] [Cited by in F6Publishing: 1195] [Article Influence: 72.7] [Reference Citation Analysis]
60 Amodio P, Schiff S, Piccolo FD, Mapelli D, Gatta A, Umiltà C. Attention Dysfunction in Cirrhotic Patients: An Inquiry on the Role of Executive Control, Attention Orienting and Focusing. Metab Brain Dis 2005;20:115-27. [DOI: 10.1007/s11011-005-4149-3] [Cited by in Crossref: 54] [Cited by in F6Publishing: 52] [Article Influence: 3.2] [Reference Citation Analysis]
61 Goyal O, Sidhu SS, Kishore H. Minimal hepatic encephalopathy in cirrhosis- how long to treat? Ann Hepatol. 2017;16:115-122. [PMID: 28051800 DOI: 10.5604/16652681.1226822] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 3.2] [Reference Citation Analysis]
62 Zucco GM, Amodio P, Gatta A. Olfactory deficits in patients affected by minimal hepatic encephalopathy: a pilot study. Chem Senses 2006;31:273-8. [PMID: 16436687 DOI: 10.1093/chemse/bjj029] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.1] [Reference Citation Analysis]
63 Marchetti P, D'Avanzo C, Orsato R, Montagnese S, Schiff S, Kaplan PW, Piccione F, Merkel C, Gatta A, Sparacino G. Electroencephalography in patients with cirrhosis. Gastroenterology. 2011;141:1680-1689.e1-2. [PMID: 21763244 DOI: 10.1053/j.gastro.2011.06.085] [Cited by in Crossref: 34] [Cited by in F6Publishing: 30] [Article Influence: 3.1] [Reference Citation Analysis]
64 Merli M, Riggio O. Dietary and nutritional indications in hepatic encephalopathy. Metab Brain Dis 2009;24:211-21. [PMID: 19052853 DOI: 10.1007/s11011-008-9127-0] [Cited by in Crossref: 24] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
65 Amodio P, Campagna F, Olianas S, Iannizzi P, Mapelli D, Penzo M, Angeli P, Gatta A. Detection of minimal hepatic encephalopathy: normalization and optimization of the Psychometric Hepatic Encephalopathy Score. A neuropsychological and quantified EEG study. J Hepatol. 2008;49:346-353. [PMID: 18602716 DOI: 10.1016/j.jhep.2008.04.022] [Cited by in Crossref: 126] [Cited by in F6Publishing: 113] [Article Influence: 9.0] [Reference Citation Analysis]
66 Rathi S, Chopra M, Chouduri G, Sharma P, Madan K, Chhabra M, Rai RR, Govil A, Konar A, Goenka M, Agarwal M, Mukherjee J, Thorat V, Salunkhe S, Abraham P, Nagral A, Jhaveri A, Bhat N, Varghese J, R S A, Ravishankar, Reddy DC, Dhiman RK. Prevalence of Minimal Hepatic Encephalopathy in Patients With Liver Cirrhosis: A Cross-Sectional, Clinicoepidemiological, Multicenter, Nationwide Study in India: The PREDICT Study. J Clin Exp Hepatol 2019;9:476-83. [PMID: 31516264 DOI: 10.1016/j.jceh.2018.09.009] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
67 Sigal SH, Stanca CM, Kontorinis N, Bodian C, Ryan E. Diabetes mellitus is associated with hepatic encephalopathy in patients with HCV cirrhosis. Am J Gastroenterol. 2006;101:1490-1496. [PMID: 16863551 DOI: 10.1111/j.1572-0241.2006.00649.x] [Cited by in Crossref: 51] [Cited by in F6Publishing: 44] [Article Influence: 3.2] [Reference Citation Analysis]
68 Sarma MK, Huda A, Nagarajan R, Hinkin CH, Wilson N, Gupta RK, Frias-Martinez E, Sayre J, Guze B, Han SH. Multi-dimensional MR spectroscopy: towards a better understanding of hepatic encephalopathy. Metab Brain Dis. 2011;26:173-184. [PMID: 21698453 DOI: 10.1007/s11011-011-9250-1] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 2.4] [Reference Citation Analysis]
69 Minemura M, Tajiri K, Shimizu Y. Systemic abnormalities in liver disease. World J Gastroenterol 2009; 15(24): 2960-2974 [PMID: 19554648 DOI: 10.3748/wjg.15.2960] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
70 Felipo V. Contribution of altered signal transduction associated to glutamate receptors in brain to the neurological alterations of hepatic encephalopathy. World J Gastroenterol 2006; 12(48): 7737-7743 [PMID: 17203513 DOI: 10.3748/wjg.v12.i48.7737] [Cited by in CrossRef: 25] [Cited by in F6Publishing: 24] [Article Influence: 1.6] [Reference Citation Analysis]
71 Montagnese S, Schiff S, De Rui M, Crossey MM, Amodio P, Taylor-Robinson SD. Neuropsychological tools in hepatology: a survival guide for the clinician. J Viral Hepat. 2012;19:307-315. [PMID: 22497809 DOI: 10.1111/j.1365-2893.2012.01592.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
72 Romero-Gómez M, Boza F, García-Valdecasas MS, García E, Aguilar-Reina J. Subclinical hepatic encephalopathy predicts the development of overt hepatic encephalopathy. Am J Gastroenterol. 2001;96:2718-2723. [PMID: 11569701 DOI: 10.1111/j.1572-0241.2001.04130.x] [Cited by in Crossref: 233] [Cited by in F6Publishing: 221] [Article Influence: 11.1] [Reference Citation Analysis]
73 Amodio P. Hepatic encephalopathy: Diagnosis and management. Liver Int. 2018;38:966-975. [PMID: 29624860 DOI: 10.1111/liv.13752] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
74 Ennaifer R, Cheikh M, Hefaiedh R, Romdhane H, Ben Nejma H, Hadj NB. [Minimal hepatic encephalopathy: a better diagnostic to improve prognostic]. Presse Med 2014;43:e127-33. [PMID: 24703736 DOI: 10.1016/j.lpm.2013.09.016] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
75 Berry K, Duarte-Rojo A, Grab JD, Dunn MA, Boyarsky BJ, Verna EC, Kappus MR, Volk ML, McAdams-DeMarco M, Segev DL, Ganger DR, Ladner DP, Shui A, Tincopa MA, Rahimi RS, Lai JC; from the Multi-Center Functional Assessment in Liver Transplantation (FrAILT) Study. Cognitive Impairment and Physical Frailty in Patients With Cirrhosis. Hepatol Commun 2021. [PMID: 34558844 DOI: 10.1002/hep4.1796] [Reference Citation Analysis]
76 Kappus MR, Bajaj JS. Assessment of minimal hepatic encephalopathy (with emphasis on computerized psychometric tests). Clin Liver Dis. 2012;16:43-55. [PMID: 22321464 DOI: 10.1016/j.cld.2011.12.002] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
77 Amodio P, De Toni EN, Cavalletto L, Mapelli D, Bernardinello E, Del Piccolo F, Bergamelli C, Costanzo R, Bergamaschi F, Poma SZ, Chemello L, Gatta A, Perini G. Mood, cognition and EEG changes during interferon α (alpha-IFN) treatment for chronic hepatitis C. Journal of Affective Disorders 2005;84:93-8. [DOI: 10.1016/j.jad.2004.09.004] [Cited by in Crossref: 37] [Cited by in F6Publishing: 33] [Article Influence: 2.2] [Reference Citation Analysis]
78 Shah NJ, Neeb H, Zaitsev M, Steinhoff S, Kircheis G, Amunts K, Häussinger D, Zilles K. Quantitative T1 mapping of hepatic encephalopathy using magnetic resonance imaging. Hepatology 2003;38:1219-26. [PMID: 14578860 DOI: 10.1053/jhep.2003.50477] [Cited by in Crossref: 58] [Cited by in F6Publishing: 51] [Article Influence: 3.1] [Reference Citation Analysis]
79 Dhiman RK, Saraswat VA, Sharma BK, Sarin SK, Chawla YK, Butterworth R, Duseja A, Aggarwal R, Amarapurkar D, Sharma P, Madan K, Shah S, Seth AK, Gupta RK, Koshy A, Rai RR, Dilawari JB, Mishra SP, Acharya SK. Minimal hepatic encephalopathy: Consensus statement of a working party of the Indian National Association for Study of the Liver: Minimal hepatic encephalopathy. Journal of Gastroenterology and Hepatology 2010;25:1029-41. [DOI: 10.1111/j.1440-1746.2010.06318.x] [Cited by in Crossref: 80] [Cited by in F6Publishing: 70] [Article Influence: 6.7] [Reference Citation Analysis]
80 Nardelli S, Riggio O, Gioia S, Merli M, Spagnoli A, di Martino M, Pelle G, Ridola L. Risk factors for hepatic encephalopathy and mortality in cirrhosis: The role of cognitive impairment, muscle alterations and shunts. Digestive and Liver Disease 2022. [DOI: 10.1016/j.dld.2021.12.015] [Reference Citation Analysis]
81 Patidar KR, Thacker LR, Wade JB, Sterling RK, Sanyal AJ, Siddiqui MS, Matherly SC, Stravitz RT, Puri P, Luketic VA, Fuchs M, White MB, Noble NA, Unser AB, Gilles H, Heuman DM, Bajaj JS. Covert hepatic encephalopathy is independently associated with poor survival and increased risk of hospitalization. Am J Gastroenterol. 2014;109:1757-1763. [PMID: 25178701 DOI: 10.1038/ajg.2014.264] [Cited by in Crossref: 99] [Cited by in F6Publishing: 79] [Article Influence: 12.4] [Reference Citation Analysis]
82 Neeb H, Dierkes T, Shah N. Quantitative T1 mapping and absolute water content measurement using MRI. International Congress Series 2004;1265:113-23. [DOI: 10.1016/j.ics.2004.02.168] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
83 Monfort P, Cauli O, Montoliu C, Rodrigo R, Llansola M, Piedrafita B, El Mlili N, Boix J, Agustí A, Felipo V. Mechanisms of cognitive alterations in hyperammonemia and hepatic encephalopathy: therapeutical implications. Neurochem Int 2009;55:106-12. [PMID: 19428813 DOI: 10.1016/j.neuint.2009.01.021] [Cited by in Crossref: 43] [Cited by in F6Publishing: 41] [Article Influence: 3.3] [Reference Citation Analysis]
84 Lewis M, Howdle PD. The neurology of liver failure. QJM. 2003;96:623-633. [PMID: 12925717 DOI: 10.1093/qjmed/hcg110] [Cited by in Crossref: 55] [Cited by in F6Publishing: 43] [Article Influence: 2.9] [Reference Citation Analysis]
85 Sidhu SS, Goyal O, Mishra BP, Sood A, Chhina RS, Soni RK. Rifaximin improves psychometric performance and health-related quality of life in patients with minimal hepatic encephalopathy (the RIME Trial). Am J Gastroenterol. 2011;106:307-316. [PMID: 21157444 DOI: 10.1038/ajg.2010.455] [Cited by in Crossref: 155] [Cited by in F6Publishing: 138] [Article Influence: 12.9] [Reference Citation Analysis]
86 Allampati S, Duarte-Rojo A, Thacker LR, Patidar KR, White MB, Klair JS, John B, Heuman DM, Wade JB, Flud C, O'Shea R, Gavis EA, Unser AB, Bajaj JS. Diagnosis of Minimal Hepatic Encephalopathy Using Stroop EncephalApp: A Multicenter US-Based, Norm-Based Study. Am J Gastroenterol. 2016;111:78-86. [PMID: 26644276 DOI: 10.1038/ajg.2015.377] [Cited by in Crossref: 76] [Cited by in F6Publishing: 63] [Article Influence: 10.9] [Reference Citation Analysis]
87 Lauridsen MM, Grønbæk H, Næser EB, Leth ST, Vilstrup H. Gender and age effects on the continuous reaction times method in volunteers and patients with cirrhosis. Metab Brain Dis 2012;27:559-65. [DOI: 10.1007/s11011-012-9318-6] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
88 Weissenborn K. Minimal hepatic encephalopathy: a permanent source of discussion. Hepatology. 2002;35:494-496. [PMID: 11826427 DOI: 10.1053/jhep.2002.31552] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 1.6] [Reference Citation Analysis]
89 Sorrell JH, Zolnikov BJ, Sharma A, Jinnai I. Cognitive impairment in people diagnosed with end-stage liver disease evaluated for liver transplantation. Psychiatry Clin Neurosci 2006;60:174-81. [DOI: 10.1111/j.1440-1819.2006.01483.x] [Cited by in Crossref: 45] [Cited by in F6Publishing: 34] [Article Influence: 2.8] [Reference Citation Analysis]
90 Suh SJ, Yim HJ, Yoon EL, Lee BJ, Hyun JJ, Jung SW, Koo JS, Kim JH, Kim KJ, Choung RS, Seo YS, Yeon JE, Um SH, Byun KS, Lee SW, Choi JH, Ryu HS. Is propofol safe when administered to cirrhotic patients during sedative endoscopy? Korean J Intern Med. 2014;29:57-65. [PMID: 24574834 DOI: 10.3904/kjim.2014.29.1.57] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 2.1] [Reference Citation Analysis]
91 Li YY, Nie YQ, Sha WH, Zeng Z, Yang FY, Ping L, Jia L. Prevalence of subclinical hepatic encephalopathy in cirrhotic patients in China. World J Gastroenterol 2004; 10(16): 2397-2401 [PMID: 15285027 DOI: 10.3748/wjg.v10.i16.2397] [Cited by in CrossRef: 46] [Cited by in F6Publishing: 46] [Article Influence: 2.6] [Reference Citation Analysis]
92 Mohamed AS, Elmeteini MA, Mohamed GAE, Elserafy DM, Elmadani AA, Hashem RE. Cognitive impairment in recipients of liver transplantation and relation to hepatic encephalopathy. Middle East Curr Psychiatry 2022;29. [DOI: 10.1186/s43045-022-00175-3] [Reference Citation Analysis]
93 Bajaj JS, Saeian K. MELD Score Does Not Discriminate Against Patients with Hepatic Encephalopathy. Dig Dis Sci 2005;50:753-6. [DOI: 10.1007/s10620-005-2568-y] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
94 Dhiman RK, Thumburu KK, Verma N, Chopra M, Rathi S, Dutta U, Singal AK, Taneja S, Duseja A, Singh M. Comparative Efficacy of Treatment Options for Minimal Hepatic Encephalopathy: A Systematic Review and Network Meta-Analysis.Clin Gastroenterol Hepatol. 2020;18:800-812.e25. [PMID: 31476436 DOI: 10.1016/j.cgh.2019.08.047] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 3.7] [Reference Citation Analysis]
95 Pellegrini A, Ubiali E, Orsato R, Schiff S, Gatta A, Castellaro A, Casagrande A, Amodio P. Electroencephalographic staging of hepatic encephalopathy by an artificial neural network and an expert system. Neurophysiol Clin. 2005;35:162-167. [PMID: 16530133 DOI: 10.1016/j.neucli.2005.12.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
96 Amodio P, Wenin H, Del Piccolo F, Mapelli D, Montagnese S, Pellegrini A, Musto C, Gatta A, Umiltà C. Variability of trail making test, symbol digit test and line trait test in normal people. A normative study taking into account age-dependent decline and sociobiological variables. Aging Clin Exp Res 2002;14:117-31. [PMID: 12092785 DOI: 10.1007/BF03324425] [Cited by in Crossref: 99] [Cited by in F6Publishing: 32] [Article Influence: 5.0] [Reference Citation Analysis]
97 Laursen TL, Sandahl TD, Kazankov K, George J, Grønbæk H. Liver-related effects of chronic hepatitis C antiviral treatment. World J Gastroenterol 2020; 26(22): 2931-2947 [PMID: 32587440 DOI: 10.3748/wjg.v26.i22.2931] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
98 Pratap Mouli V, Benjamin J, Bhushan Singh M, Mani K, Garg SK, Saraya A, Joshi YK. Effect of probiotic VSL#3 in the treatment of minimal hepatic encephalopathy: A non-inferiority randomized controlled trial. Hepatol Res. 2015;45:880-889. [PMID: 25266207 DOI: 10.1111/hepr.12429] [Cited by in Crossref: 24] [Cited by in F6Publishing: 27] [Article Influence: 3.0] [Reference Citation Analysis]
99 Kircheis G, Bode JG, Hilger N, Kramer T, Schnitzler A, Häussinger D. Diagnostic and prognostic values of critical flicker frequency determination as new diagnostic tool for objective HE evaluation in patients undergoing TIPS implantation. Eur J Gastroenterol Hepatol. 2009;21:1383-1394. [PMID: 19738480 DOI: 10.1097/MEG.0b013e328310e0c3] [Cited by in Crossref: 24] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
100 Luo M, Li L, Lu CZ, Cao WK. Clinical efficacy and safety of lactulose for minimal hepatic encephalopathy: a meta-analysis. Eur J Gastroenterol Hepatol. 2011;23:1250-1257. [PMID: 21971378 DOI: 10.1097/meg.0b013e32834d1938] [Cited by in Crossref: 43] [Cited by in F6Publishing: 22] [Article Influence: 4.3] [Reference Citation Analysis]
101 Agrawal S, Umapathy S, Dhiman RK. Minimal hepatic encephalopathy impairs quality of life. J Clin Exp Hepatol. 2015;5:S42-S48. [PMID: 26041957 DOI: 10.1016/j.jceh.2014.11.006] [Cited by in Crossref: 38] [Cited by in F6Publishing: 31] [Article Influence: 4.8] [Reference Citation Analysis]
102 Kato A, Watanabe Y, Sawara K, Suzuki K. Diagnosis of sub-clinical hepatic encephalopathy by Neuropsychological Tests (NP-tests). Hepatology Research 2008;38:S122-7. [DOI: 10.1111/j.1872-034x.2008.00437.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
103 D'Amico G, Garcia-Tsao G, Pagliaro L. Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. J Hepatol. 2006;44:217-231. [PMID: 16298014 DOI: 10.1016/j.jhep.2005.10.013] [Cited by in Crossref: 1547] [Cited by in F6Publishing: 1305] [Article Influence: 91.0] [Reference Citation Analysis]
104 Ziada DH, Soliman HH, El Yamany SA, Hamisa MF, Hasan AM. Can Lactobacillus acidophilus improve minimal hepatic encephalopathy? Arab J Gastroenterol. 2013;14:116-122. [PMID: 24206740 DOI: 10.1016/j.ajg.2013.08.002] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 3.0] [Reference Citation Analysis]
105 Harris MK, Elliott D, Schwendimann RN, Minagar A, Jaffe SL. Neurologic Presentations of Hepatic Disease. Neurologic Clinics 2010;28:89-105. [DOI: 10.1016/j.ncl.2009.09.016] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
106 Serper M, Kaplan DE, Lin M, Taddei TH, Parikh ND, Werner RM, Tapper EB. Inpatient Gastroenterology Consultation and Outcomes of Cirrhosis-Related Hospitalizations in Two Large National Cohorts. Dig Dis Sci 2021. [PMID: 34374917 DOI: 10.1007/s10620-021-07150-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
107 Ferenci P. Diagnosis of minimal hepatic encephalopathy: still a challenge. Gut 2013;62:1394-1394. [DOI: 10.1136/gutjnl-2012-304270] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
108 Duarte-Rojo A, Ruiz-Margáin A, Macias-Rodriguez RU, Cubero FJ, Estradas-Trujillo J, Muñoz-Fuentes RM, Torre A. Clinical scenarios for the use of S100β as a marker of hepatic encephalopathy. World J Gastroenterol 2016; 22(17): 4397-4402 [PMID: 27158209 DOI: 10.3748/wjg.v22.i17.4397] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
109 Amodio P, Caregaro L, Pattenò E, Marcon M, Del Piccolo F, Gatta A. Vegetarian diets in hepatic encephalopathy: facts or fantasies? Dig Liver Dis 2001;33:492-500. [PMID: 11572577 DOI: 10.1016/s1590-8658(01)80028-1] [Cited by in Crossref: 21] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
110 Amodio P, Montagnese S, Gatta A, Morgan MY. Characteristics of Minimal Hepatic Encephalopathy. Metab Brain Dis 2004;19:253-67. [DOI: 10.1023/b:mebr.0000043975.01841.de] [Cited by in Crossref: 196] [Cited by in F6Publishing: 76] [Article Influence: 10.9] [Reference Citation Analysis]
111 Bianchi G, Giovagnoli M, Sasdelli AS, Marchesini G. Hepatic encephalopathy and health-related quality of life. Clin Liver Dis 2012;16:159-70. [PMID: 22321471 DOI: 10.1016/j.cld.2011.12.003] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
112 Özbaş B, Keskin O, Hecker H, Karahan I, Özbaş C, Kalkan Ç, Kartal A, Önder FO, Öncü BK, Gençdal G, Akyildiz M, Günşar F, Idilman R, Weissenborn K, Özütemiz Ö, Yurdaydin C. Determination of Turkish norms of psychometric tests for diagnosing minimal hepatic encephalopathy and proposal of a high sensitive screening test battery. Hepatol Int 2021. [PMID: 34085147 DOI: 10.1007/s12072-021-10207-5] [Reference Citation Analysis]
113 Fontana RJ, Bieliauskas LA, Back-Madruga C, Lindsay KL, Litman HJ, Lok AS, Kronfol Z; HALT-C Trial Group. Cognitive function does not worsen during long-term low-dose peginterferon therapy in patients with chronic hepatitis C. Am J Gastroenterol 2010;105:1551-60. [PMID: 20104219 DOI: 10.1038/ajg.2010.3] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
114 Amodio P, Pellegrini A, Ubiali E, Mathy I, Piccolo FD, Orsato R, Gatta A, Guerit J. The EEG assessment of low-grade hepatic encephalopathy: Comparison of an artificial neural network-expert system (ANNES) based evaluation with visual EEG readings and EEG spectral analysis. Clinical Neurophysiology 2006;117:2243-51. [DOI: 10.1016/j.clinph.2006.06.714] [Cited by in Crossref: 41] [Cited by in F6Publishing: 31] [Article Influence: 2.6] [Reference Citation Analysis]
115 Erceg S, Monfort P, Cauli O, Montoliu C, Llansola M, Piedrafita B, Felipo V. Role of extracellular cGMP and of hyperammonemia in the impairment of learning in rats with chronic hepatic failure. Therapeutic implications. Neurochem Int 2006;48:441-6. [PMID: 16497413 DOI: 10.1016/j.neuint.2005.10.016] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.2] [Reference Citation Analysis]
116 Amodio P, Del Piccolo F, Pettenò E, Mapelli D, Angeli P, Iemmolo R, Muraca M, Musto C, Gerunda G, Rizzo C, Merkel C, Gatta A. Prevalence and prognostic value of quantified electroencephalogram (EEG) alterations in cirrhotic patients. Journal of Hepatology 2001;35:37-45. [DOI: 10.1016/s0168-8278(01)00129-5] [Cited by in Crossref: 167] [Cited by in F6Publishing: 44] [Article Influence: 8.0] [Reference Citation Analysis]
117 Morgello S, Estanislao L, Ryan E, Gerits P, Simpson D, Verma S, DiRocco A, Sharp V;  Manhattan HIV Brain Bank. Effects of hepatic function and hepatitis C virus on the nervous system assessment of advanced-stage HIV-infected individuals. AIDS. 2005;19 Suppl 3:S116-S122. [PMID: 16251806 DOI: 10.1097/01.aids.0000192079.49185.f9] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 1.7] [Reference Citation Analysis]
118 Bale A, Pai CG, Shetty S, Balaraju G, Shetty A. Prevalence of and Factors Associated With Minimal Hepatic Encephalopathy in Patients With Cirrhosis of Liver. J Clin Exp Hepatol 2018;8:156-61. [PMID: 29892178 DOI: 10.1016/j.jceh.2017.06.005] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
119 Czarnecka A, Milewski K, Zielińska M. Asymmetric Dimethylarginine and Hepatic Encephalopathy: Cause, Effect or Association? Neurochem Res 2017;42:750-61. [PMID: 27885576 DOI: 10.1007/s11064-016-2111-x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
120 Amodio P, Ridola L, Schiff S, Montagnese S, Pasquale C, Nardelli S, Pentassuglio I, Trezza M, Marzano C, Flaiban C, Angeli P, Cona G, Bisiacchi P, Gatta A, Riggio O. Improving the inhibitory control task to detect minimal hepatic encephalopathy. Gastroenterology. 2010;139:510-518, 518.e1-518.e2. [PMID: 20470775 DOI: 10.1053/j.gastro.2010.04.057] [Cited by in Crossref: 64] [Cited by in F6Publishing: 56] [Article Influence: 5.3] [Reference Citation Analysis]
121 Mardini H, Saxby BK, Record CO. Computerized psychometric testing in minimal encephalopathy and modulation by nitrogen challenge and liver transplant. Gastroenterology. 2008;135:1582-1590. [PMID: 18647604 DOI: 10.1053/j.gastro.2008.06.043] [Cited by in Crossref: 58] [Cited by in F6Publishing: 48] [Article Influence: 4.1] [Reference Citation Analysis]
122 Saab S, Han S, Martin P. LIVER TRANSPLANTATION. Clinics in Liver Disease 2000;4:513-32. [DOI: 10.1016/s1089-3261(05)70124-0] [Cited by in Crossref: 8] [Article Influence: 0.4] [Reference Citation Analysis]
123 Schiff S, Mapelli D, Vallesi A, Orsato R, Gatta A, Umiltà C, Amodio P. Top-down and bottom-up processes in the extrastriate cortex of cirrhotic patients: An ERP study. Clinical Neurophysiology 2006;117:1728-36. [DOI: 10.1016/j.clinph.2006.04.020] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 1.4] [Reference Citation Analysis]
124 Mapelli D, Iannizzi P, Biancardi A, Schiff S, Del Piccolo F, Valenti P, Amodio P. Neuropsychological dysfunction in minimal hepatic encephalopathy: a review compared with own experience. In: Häussinger D, Kircheis G, Schliess F, editors. Hepatic Encephalopathy and Nitrogen Metabolism. Dordrecht: Springer Netherlands; 2006. pp. 467-73. [DOI: 10.1007/1-4020-4456-9_36] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
125 Luo M, Ma P, Li L, Cao WK. Advances in psychometric tests for screening minimal hepatic encephalopathy: From paper-and-pencil to computer-aided assessment. Turk J Gastroenterol 2019;30:398-407. [PMID: 31060994 DOI: 10.5152/tjg.2019.18226] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
126 Garcia-Tsao G. Portal hypertension. Curr Opin Gastroenterol 2000;16:282-9. [PMID: 17023887 DOI: 10.1097/00001574-200005000-00012] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
127 Ampuero J, Simón M, Montoliú C, Jover R, Serra MÁ, Córdoba J, Romero-Gómez M. Minimal hepatic encephalopathy and critical flicker frequency are associated with survival of patients with cirrhosis. Gastroenterology 2015;149:1483-9. [PMID: 26299413 DOI: 10.1053/j.gastro.2015.07.067] [Cited by in Crossref: 74] [Cited by in F6Publishing: 60] [Article Influence: 10.6] [Reference Citation Analysis]
128 Juan Z, Chen J, Ding B, Yongping L, Liu K, Wang L, Le Y, Liao Q, Shi J, Huang J, Wu Y, Ma D, Ouyang W, Tong J. Probiotic supplement attenuates chemotherapy-related cognitive impairment in patients with breast cancer: a randomised, double-blind, and placebo-controlled trial. Eur J Cancer 2022;161:10-22. [PMID: 34896904 DOI: 10.1016/j.ejca.2021.11.006] [Reference Citation Analysis]
129 Romero-Gómez M, Ramos-Guerrero R, Grande L, de Terán LC, Corpas R, Camacho I, Bautista JD. Intestinal glutaminase activity is increased in liver cirrhosis and correlates with minimal hepatic encephalopathy. J Hepatol. 2004;41:49-54. [PMID: 15246207 DOI: 10.1016/j.jhep.2004.03.021] [Cited by in Crossref: 70] [Cited by in F6Publishing: 60] [Article Influence: 4.1] [Reference Citation Analysis]
130 Reuben A. There is nothin' like a Dame. Hepatology 2002;35:983-5. [PMID: 11915054 DOI: 10.1053/jhep.2002.0350983] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
131 Maharshi S, Sharma BC, Sachdeva S, Srivastava S, Sharma P. Efficacy of Nutritional Therapy for Patients With Cirrhosis and Minimal Hepatic Encephalopathy in a Randomized Trial. Clin Gastroenterol Hepatol 2016; 14: 454-460. quiz e33. [PMID: 26453952 DOI: 10.1016/j.cgh.2015.09.028] [Cited by in Crossref: 47] [Cited by in F6Publishing: 40] [Article Influence: 6.7] [Reference Citation Analysis]
132 Fontana RJ, Bieliauskas LA, Back-Madruga C, Lindsay KL, Kronfol Z, Lok AS, Padmanabhan L. Cognitive function in hepatitis C patients with advanced fibrosis enrolled in the HALT-C trial. J Hepatol. 2005;43:614-622. [PMID: 16237784 DOI: 10.1016/j.jhep.2005.04.006] [Cited by in Crossref: 61] [Cited by in F6Publishing: 61] [Article Influence: 3.6] [Reference Citation Analysis]
133 Weissenborn K. Challenges in diagnosing hepatic encephalopathy. Neurochem Res 2015;40:265-73. [PMID: 25142937 DOI: 10.1007/s11064-014-1416-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
134 Nardelli S, Gioia S, Ridola L, Farcomeni A, Merli M, Riggio O. Proton Pump Inhibitors Are Associated With Minimal and Overt Hepatic Encephalopathy and Increased Mortality in Patients With Cirrhosis. Hepatology. 2018;. [PMID: 30289992 DOI: 10.1002/hep.30304] [Cited by in Crossref: 34] [Cited by in F6Publishing: 23] [Article Influence: 11.3] [Reference Citation Analysis]
135 Chen HJ, Chen R, Yang M, Teng GJ, Herskovits EH. Identification of minimal hepatic encephalopathy in patients with cirrhosis based on white matter imaging and Bayesian data mining. AJNR Am J Neuroradiol 2015;36:481-7. [PMID: 25500314 DOI: 10.3174/ajnr.A4146] [Cited by in Crossref: 20] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
136 Liu Q, Duan ZP, Ha DK, Bengmark S, Kurtovic J, Riordan SM. Synbiotic modulation of gut flora: effect on minimal hepatic encephalopathy in patients with cirrhosis. Hepatology. 2004;39:1441-1449. [PMID: 15122774 DOI: 10.1002/hep.20194] [Cited by in Crossref: 406] [Cited by in F6Publishing: 367] [Article Influence: 22.6] [Reference Citation Analysis]
137 Taneja S, Dhiman RK, Khatri A, Goyal S, Thumbru KK, Agarwal R, Duseja A, Chawla Y. Inhibitory control test for the detection of minimal hepatic encephalopathy in patients with cirrhosis of liver. J Clin Exp Hepatol. 2012;2:306-314. [PMID: 25755452 DOI: 10.1016/j.jceh.2012.07.001] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
138 Sidhu SS, Goyal O, Parker RA, Kishore H, Sood A. Rifaximin vs. lactulose in treatment of minimal hepatic encephalopathy. Liver Int. 2016;36:378-385. [PMID: 26201713 DOI: 10.1111/liv.12921] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 4.3] [Reference Citation Analysis]
139 Campagna F, Montagnese S, Schiff S, Biancardi A, Mapelli D, Angeli P, Poci C, Cillo U, Merkel C, Gatta A. Cognitive impairment and electroencephalographic alterations before and after liver transplantation: what is reversible? Liver Transpl. 2014;20:977-986. [PMID: 24809329 DOI: 10.1002/lt.23909] [Cited by in Crossref: 38] [Cited by in F6Publishing: 39] [Article Influence: 5.4] [Reference Citation Analysis]
140 Singh J, Sharma BC, Maharshi S, Puri V, Srivastava S. Spectral electroencephalogram in liver cirrhosis with minimal hepatic encephalopathy before and after lactulose therapy. J Gastroenterol Hepatol. 2016;31:1203-1209. [PMID: 26716736 DOI: 10.1111/jgh.13283] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
141 Amodio P, Cordoba J. Smart applications for assessing minimal hepatic encephalopathy: novelty from the app revolution. Hepatology. 2013;58:844-846. [PMID: 23532934 DOI: 10.1002/hep.26416] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
142 Rai R, Ahuja CK, Agrawal S, Kalra N, Duseja A, Khandelwal N, Chawla Y, Dhiman RK. Reversal of Low-Grade Cerebral Edema After Lactulose/Rifaximin Therapy in Patients with Cirrhosis and Minimal Hepatic Encephalopathy. Clin Transl Gastroenterol 2015;6:e111. [PMID: 26378384 DOI: 10.1038/ctg.2015.38] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 3.4] [Reference Citation Analysis]
143 Das A, Dhiman RK, Saraswat VA, Verma M, Naik SR. Prevalence and natural history of subclinical hepatic encephalopathy in cirrhosis. J Gastroenterol Hepatol. 2001;16:531-535. [PMID: 11350549 DOI: 10.1046/j.1440-1746.2001.02487.x] [Cited by in Crossref: 207] [Cited by in F6Publishing: 186] [Article Influence: 9.9] [Reference Citation Analysis]
144 Burroughs TK, Wade JB, Ellwood MS, Fagan A, Heuman DM, Fuchs M, Bajaj JS. Effect of Post-Traumatic Stress Disorder on Cognitive Function and Covert Hepatic Encephalopathy Diagnosis in Cirrhotic Veterans. Dig Dis Sci 2018;63:481-5. [PMID: 29313245 DOI: 10.1007/s10620-017-4894-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
145 Riggio O, Ridola L, Pasquale C, Pentassuglio I, Nardelli S, Moscucci F, Merli M, Montagnese S, Amodio P, Merkel C. A simplified psychometric evaluation for the diagnosis of minimal hepatic encephalopathy. Clin Gastroenterol Hepatol. 2011;9:613-616.e1. [PMID: 21440091 DOI: 10.1016/j.cgh.2011.03.017] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 1.6] [Reference Citation Analysis]
146 Grover VP, Crossey MM, Fitzpatrick JA, Saxby BK, Shaw R, Waldman AD, Morgan MY, Taylor-Robinson SD. Quantitative magnetic resonance imaging in patients with cirrhosis: a cross-sectional study. Metab Brain Dis 2016;31:1315-25. [PMID: 26251205 DOI: 10.1007/s11011-015-9716-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
147 Häussinger D, Córdoba J, Kircheis G, Vilstrup H, Fleig WE, Jones EA, Schleiss F, Blei AT. Definition and assessment of low-grade hepatic encephalopathy. In: Häussinger D, Kircheis G, Schliess F, editors. Hepatic Encephalopathy and Nitrogen Metabolism. Dordrecht: Springer Netherlands; 2006. pp. 423-32. [DOI: 10.1007/1-4020-4456-9_32] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
148 Attia M, Al-radadi NS. Nano optical sensor binuclear Pt-2-pyrazinecarboxylic acid –bipyridine for enhancement of the efficiency of 3-nitrotyrosine biomarker for early diagnosis of liver cirrhosis with minimal hepatic encephalopathy. Biosensors and Bioelectronics 2016;86:406-12. [DOI: 10.1016/j.bios.2016.06.074] [Cited by in Crossref: 21] [Cited by in F6Publishing: 13] [Article Influence: 3.5] [Reference Citation Analysis]
149 Mladenović D, Hrnčić D, Rašić-marković A, Puškaš N, Petrovich S, Stanojlović O. Spectral analysis of thioacetamide-induced electroencephalographic changes in rats. Hum Exp Toxicol 2013;32:90-100. [DOI: 10.1177/0960327112456312] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
150 Montagnese S, Schiff S, Turco M, Bonato CA, Ridola L, Gatta A, Nousbaum J, Riggio O, Merkel C, Amodio P. Simple tools for complex syndromes: A three-level difficulty test for hepatic encephalopathy. Digestive and Liver Disease 2012;44:957-60. [DOI: 10.1016/j.dld.2012.06.010] [Cited by in Crossref: 27] [Cited by in F6Publishing: 21] [Article Influence: 2.7] [Reference Citation Analysis]
151 Ortiz M, Jacas C, Córdoba J. Minimal hepatic encephalopathy: diagnosis, clinical significance and recommendations. Journal of Hepatology 2005;42:S45-53. [DOI: 10.1016/j.jhep.2004.11.028] [Cited by in Crossref: 178] [Cited by in F6Publishing: 166] [Article Influence: 10.5] [Reference Citation Analysis]
152 Schiff S, D'Avanzo C, Cona G, Goljahani A, Montagnese S, Volpato C, Gatta A, Sparacino G, Amodio P, Bisiacchi P. Insight into the relationship between brain/behavioral speed and variability in patients with minimal hepatic encephalopathy. Clin Neurophysiol 2014;125:287-97. [PMID: 24035204 DOI: 10.1016/j.clinph.2013.08.004] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
153 Bisiacchi P, Cona G, Tarantino V, Schiff S, Montagnese S, Amodio P, Capizzi G. Assessing inter- and intra-individual cognitive variability in patients at risk for cognitive impairment: the case of minimal hepatic encephalopathy. Metab Brain Dis 2014;29:945-53. [PMID: 24682793 DOI: 10.1007/s11011-014-9529-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
154 Jesús Maldonado-garza H, Vázquez-elizondo G, Obed Gaytán-torres J, Ricardo Flores-rendón Á, Graciela Cárdenas-sandoval M, Javier Bosques-padilla F. Prevalence of minimal hepatic encephalopathy in cirrhotic patients. Annals of Hepatology 2011;10:S40-4. [DOI: 10.1016/s1665-2681(19)31605-9] [Cited by in Crossref: 19] [Article Influence: 1.7] [Reference Citation Analysis]
155 Kircheis G, Knoche A, Hilger N, Manhart F, Schnitzler A, Schulze H, Häussinger D. Hepatic encephalopathy and fitness to drive. Gastroenterology 2009;137:1706-15.e1-9. [PMID: 19686744 DOI: 10.1053/j.gastro.2009.08.003] [Cited by in Crossref: 101] [Cited by in F6Publishing: 80] [Article Influence: 7.8] [Reference Citation Analysis]
156 Shawcross DL. Diagnosis and management of hepatic encephalopathy. Br J Nurs 2018;27:S7-S13. [PMID: 29411990 DOI: 10.12968/bjon.2018.27.Sup3.S7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
157 Zarantonello L, Turco M, Formentin C, Izquierdo-Altarejos P, Vuerich A, Barcenas Jimenez MJ, Montoliu C, Felipo V, Angeli P, Amodio P, Montagnese S. The influence of HE history, HE status and neuropsychological test type on learning ability in patients with cirrhosis. Liver Int 2019;39:861-70. [PMID: 30658006 DOI: 10.1111/liv.14046] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
158 Gad YZ, Zaher AA, Moussa NH, El-desoky AE, Al-Adarosy HA. Screening for minimal hepatic encephalopathy in asymptomatic drivers with liver cirrhosis. Arab J Gastroenterol. 2011;12:58-61. [PMID: 21684474 DOI: 10.1016/j.ajg.2011.04.002] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
159 Ridola L, Nardelli S, Gioia S, Riggio O. Quality of life in patients with minimal hepatic encephalopathy. World J Gastroenterol 2018; 24(48): 5446-5453 [PMID: 30622374 DOI: 10.3748/wjg.v24.i48.5446] [Cited by in CrossRef: 23] [Cited by in F6Publishing: 18] [Article Influence: 5.8] [Reference Citation Analysis]
160 Ding S, Liu L, Jing H, Xie J, Wang X, Mao J, Chen B, Zhuge Q. Dopamine from cirrhotic liver contributes to the impaired learning and memory ability of hippocampus in minimal hepatic encephalopathy. Hepatol Int 2013;7:923-36. [PMID: 26201931 DOI: 10.1007/s12072-013-9431-6] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
161 Kircheis G, Görtelmeyer R, Fleig WE, Häussinger D. Critical assessment of the PHES test battery in patients with low-grade hepatic encephalopathy. In: Häussinger D, Kircheis G, Schliess F, editors. Hepatic Encephalopathy and Nitrogen Metabolism. Dordrecht: Springer Netherlands; 2006. pp. 495-502. [DOI: 10.1007/1-4020-4456-9_39] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
162 Nie YQ, Li YY, Sha WH, Zeng Z, Hu ZW, Yang FY, Ping L, Jia L. Prevalence of subclinical hepatic encephalopathy in patients with cirrhosis determined by psychometric tests. Chinese Journal of Digestive Diseases 2002;3:145-9. [DOI: 10.1046/j.1443-9573.2002.00096.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
163 Prasad S, Dhiman RK, Duseja A, Chawla YK, Sharma A, Agarwal R. Lactulose improves cognitive functions and health-related quality of life in patients with cirrhosis who have minimal hepatic encephalopathy. Hepatology. 2007;45:549-559. [PMID: 17326150 DOI: 10.1002/hep.21533] [Cited by in Crossref: 385] [Cited by in F6Publishing: 325] [Article Influence: 25.7] [Reference Citation Analysis]